- Home
- CNET vs SNPX Comparison
CNET vs SNPX Comparison
Compare CNET & SNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNET
- SNPX
- Stock Information
- Founded
- CNET 2003
- SNPX 2012
- Country
- CNET China
- SNPX United States
- Employees
- CNET N/A
- SNPX N/A
- Industry
- CNET Advertising
- SNPX Medicinal Chemicals and Botanical Products
- Sector
- CNET Consumer Discretionary
- SNPX Health Care
- Exchange
- CNET Nasdaq
- SNPX Nasdaq
- Market Cap
- CNET 3.2M
- SNPX 3.7M
- IPO Year
- CNET N/A
- SNPX N/A
- Fundamental
- Price
- CNET $1.63
- SNPX $3.30
- Analyst Decision
- CNET
- SNPX Strong Buy
- Analyst Count
- CNET 0
- SNPX 1
- Target Price
- CNET N/A
- SNPX $14.00
- AVG Volume (30 Days)
- CNET 30.2K
- SNPX 33.7K
- Earning Date
- CNET 11-19-2024
- SNPX 11-12-2024
- Dividend Yield
- CNET N/A
- SNPX N/A
- EPS Growth
- CNET N/A
- SNPX N/A
- EPS
- CNET N/A
- SNPX N/A
- Revenue
- CNET $18,458,000.00
- SNPX N/A
- Revenue This Year
- CNET N/A
- SNPX N/A
- Revenue Next Year
- CNET N/A
- SNPX N/A
- P/E Ratio
- CNET N/A
- SNPX N/A
- Revenue Growth
- CNET N/A
- SNPX N/A
- 52 Week Low
- CNET $1.43
- SNPX $2.32
- 52 Week High
- CNET $4.96
- SNPX $7.23
- Technical
- Relative Strength Index (RSI)
- CNET 44.19
- SNPX 51.02
- Support Level
- CNET $1.43
- SNPX $3.10
- Resistance Level
- CNET $1.72
- SNPX $3.58
- Average True Range (ATR)
- CNET 0.14
- SNPX 0.33
- MACD
- CNET -0.02
- SNPX -0.03
- Stochastic Oscillator
- CNET 30.30
- SNPX 32.04
About CNET ZW Data Action Technologies Inc.
ZW Data Action Technologies Inc is engaged in providing Internet advertising, precision marketing, e-commerce online to offline (O2O) advertising and marketing services as well as the related data and technical services to small and medium enterprises in the PRC. It offers a variety channels of advertising and marketing services through its system, including distribution of the right to use search engine marketing services, provision of online advertising placements on its web portals, provision of ecommerce O2O advertising and marketing services and provision of other related value-added data and technical services to maximize market exposure and effectiveness for clients.
About SNPX Synaptogenix Inc.
Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. It is also evaluating bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.